Trials / Recruiting
RecruitingNCT06325852
Directional Bilateral Thalamic Patterned Stimulation (Chronos)
Directional Bilateral Thalamic Patterned Stimulation in Individuals with Essential Tremor
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Alfonso Fasano · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Population Size and Eligible Patients: The investigators aim to recruit 5 to 10 patients with tremors who have previously undergone Ventral Intermedius Deep Brain Stimulation (VIM-DBS) treatment but have experienced early or late loss of benefits. Additionally, the investigators will enroll ten patients with essential tremor who require VIM-DBS surgery. These individuals will undergo bilateral implantation of Boston Scientific Genus Implantable Pulse Generator (IPG) devices, connected to Boston Scientific Cartesia™ 8-contact Directional Leads. Study Design: This study comprises two distinct phases. Phase 1 is a cross-sectional investigation designed to identify the optimal algorithm for patterned stimulation in the VIM region . Phase 2 is a prospective clinical trial focusing on the assessment of safety and efficacy of bilateral VIM-DBS in patients with essential tremor. Objectives: The primary objective in Phase 2 is to evaluate the safety and effectiveness of bilateral VIM-DBS in individuals with essential tremor. In Phase 1, the investigators seek to explore the impact of the Chronos programming software on tremor patients who have experienced early or late loss of benefits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | DBS programing | The physician will utilize the Boston Scientific Chronos Clinician Programmer (software) to make adjustments to the Deep Brain Stimulation (DBS) settings for the patients. |
Timeline
- Start date
- 2024-07-16
- Primary completion
- 2026-04-01
- Completion
- 2027-01-01
- First posted
- 2024-03-22
- Last updated
- 2024-11-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06325852. Inclusion in this directory is not an endorsement.